Merck ends I-vation deal

Merck (NYSE:MRK) ended a 2007 deal with SurModics (NASDAQ:SRDX) to develop SurModics' I-vation sustained delivery system for

Read the full 178 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE